These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2557533)

  • 21. Different modes of action of 3-amino-1-hydroxy-2-pyrrolidone (HA-966) and 7-chlorokynurenic acid in the modulation of N-methyl-D-aspartate-sensitive glutamate receptors.
    Danysz W; Fadda E; Wroblewski JT; Costa E
    Mol Pharmacol; 1989 Dec; 36(6):912-6. PubMed ID: 2574820
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adaptive changes in the N-methyl-D-aspartate receptor complex after chronic treatment with imipramine and 1-aminocyclopropanecarboxylic acid.
    Nowak G; Trullas R; Layer RT; Skolnick P; Paul IA
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1380-6. PubMed ID: 8099620
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Putative NMDA receptors in Hydra: a biochemical and functional study.
    Pierobon P; Sogliano C; Minei R; Tino A; Porcu P; Marino G; Tortiglione C; Concas A
    Eur J Neurosci; 2004 Nov; 20(10):2598-604. PubMed ID: 15548203
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glycine site associated with the NMDA receptor modulates long-term potentiation.
    Oliver MW; Kessler M; Larson J; Schottler F; Lynch G
    Synapse; 1990; 5(4):265-70. PubMed ID: 2163119
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Zinc and ifenprodil allosterically inhibit two separate polyamine-sensitive sites at N-methyl-D-aspartate receptor complex.
    Berger ML; Rebernik P
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1584-91. PubMed ID: 10336556
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NMDA receptor activation by spermine requires glutamate but not glycine.
    Marvizón JC; Baudry M
    Eur J Pharmacol; 1993 Jan; 244(1):103-4. PubMed ID: 8093599
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Agonist-like character of the (R)-enantiomer of 1-hydroxy-3-amino-pyrrolid-2-one (HA-966).
    Pullan LM; Verticelli AM; Paschetto KA
    Eur J Pharmacol; 1991 Sep; 208(1):25-9. PubMed ID: 1834473
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [3H]MK801 binding to the N-methyl-D-aspartate receptor reveals drug interactions with the zinc and magnesium binding sites.
    Reynolds IJ; Miller RJ
    J Pharmacol Exp Ther; 1988 Dec; 247(3):1025-31. PubMed ID: 2849655
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of polyamines having agonist, antagonist, and inverse agonist effects at the polyamine recognition site of the NMDA receptor.
    Williams K; Dawson VL; Romano C; Dichter MA; Molinoff PB
    Neuron; 1990 Aug; 5(2):199-208. PubMed ID: 2166545
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Allosteric interactions and modulator requirement for NMDA receptor function.
    Marvizón JC; Baudry M
    Eur J Pharmacol; 1994 Oct; 269(2):165-75. PubMed ID: 7531646
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [3H]dizocilpine association kinetics distinguish stimulatory and inhibitory polyamine sites of N-methyl-D-aspartate receptors.
    Marvizón JC; Baudry M
    J Neurochem; 1994 Sep; 63(3):963-71. PubMed ID: 7914227
    [TBL] [Abstract][Full Text] [Related]  

  • 32. N-methyl-D-aspartate receptors: different subunit requirements for binding of glutamate antagonists, glycine antagonists, and channel-blocking agents.
    Lynch DR; Anegawa NJ; Verdoorn T; Pritchett DB
    Mol Pharmacol; 1994 Mar; 45(3):540-5. PubMed ID: 7511781
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Block of the N-methyl-D-aspartate receptor by remacemide and its des-glycine metabolite.
    Subramaniam S; Donevan SD; Rogawski MA
    J Pharmacol Exp Ther; 1996 Jan; 276(1):161-8. PubMed ID: 8558426
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glycine binding sites of presynaptic NMDA receptors may tonically regulate glutamate release in the rat visual cortex.
    Li YH; Han TZ
    J Neurophysiol; 2007 Jan; 97(1):817-23. PubMed ID: 17093111
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glutamate and glycine co-activate while polyamines merely modulate the NMDA receptor complex.
    Lehmann J; Colpaert F; Canton H
    Prog Neuropsychopharmacol Biol Psychiatry; 1991; 15(2):183-90. PubMed ID: 1678540
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polyamines modulate [3H]L-689,560 binding to the glycine site of the NMDA receptor from rat brain.
    Grimwood S; Struthers L; Foster AC
    Eur J Pharmacol; 1994 Jan; 266(1):43-50. PubMed ID: 8137882
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of a novel structural class of positive modulators of the N-methyl-D-aspartate receptor, with actions mediated through the glycine recognition site.
    Monahan JB; Hood WF; Compton RP; Cordi AA; Williams RM
    Eur J Pharmacol; 1990 Dec; 189(6):373-9. PubMed ID: 1963601
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ifenprodil is a novel type of N-methyl-D-aspartate receptor antagonist: interaction with polyamines.
    Reynolds IJ; Miller RJ
    Mol Pharmacol; 1989 Nov; 36(5):758-65. PubMed ID: 2555674
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complex allosteric modulation of the binding of the NMDA receptor antagonist [3H]CGP39653.
    Oblin A; Schoemaker H
    Eur J Pharmacol; 1994 Jan; 266(1):103-6. PubMed ID: 7907987
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NMDA receptor antagonists that bind to the strychnine-insensitive glycine site and inhibit NMDA-induced Ca2+ fluxes and [3H]GABA release.
    Reynolds IJ; Harris KM; Miller RJ
    Eur J Pharmacol; 1989 Mar; 172(1):9-17. PubMed ID: 2541002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.